Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Delphine, Bertram"'
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.1094-1103. ⟨10.1016/j.bulcan.2019.09.007⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.1094-1103. ⟨10.1016/j.bulcan.2019.09.007⟩
Summary Care, teaching, and research are all priorities of the French public teaching hospitals. In 2004, the remuneration method evolved from a global endowment to a fee-for-services system, based on the use of bibliometric tools. These were used in
Autor:
Laure Peyro Saint Paul, Delphine Bertram, Anne Gimbert, Violaine Blandamour, Jean-Jacques Parienti, groupe Revise, Henri Marfin, Gilles Defer, Sophie Fedrizzi, Alpha Diallo, Sabrina Crépin
Publikováno v:
Therapies. 71:475-481
Resume Depuis le decret d’application de 2006 modifiant la loi de Sante publique relative aux recherches biomedicales, les donnees de securite sont gerees par le vigilant du promoteur. La redaction du rapport final est reglementairement sous la res
Publikováno v:
Pharmaceutical Medicine. 30:221-231
Public access to human drug safety or pharmacovigilance (PV) data is a matter of interest to patients as well as to researchers and prescribers. The objective of the present study was to identify databases with open access and to analyse the accessib
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.226-236. ⟨10.1016/j.bulcan.2018.10.006⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.226-236. ⟨10.1016/j.bulcan.2018.10.006⟩
Summary Introduction Research activity evaluation in French hospitals is based on the number of publications, author position (first, second, third, second-to-last, last, investigator list, and “Other”) and journal category (A being the highest c
Autor:
Delphine Bertram, Alice Fouretier
Publikováno v:
Expert Review of Medical Devices. 11:351-359
Medical devices (MDs) contribute to improve quality and effectiveness of healthcare. The MD industry is a heterogeneous, innovative, dynamic and growing sector. The existing regulatory framework for MDs has been in place for 20 years and needed a rev
Autor:
Delphine Bertram, Florence Margraff
Publikováno v:
Drug Safety. 37:409-419
The modalities and contributions to drug safety of patient adverse drug reaction reporting systems in 50 countries have been reviewed and analysed.The means made available by National Health Competent Authorities (NCAs) for patients to report drug si
Autor:
Henri, Marfin, Sophie, Fedrizzi, Sabrina, Crépin, Jean-Jacques, Parienti, Anne, Gimbert, Violaine, Blandamour, Alpha, Diallo, Gilles, Defer, Delphine, Bertram, Laure, Peyro Saint Paul
Publikováno v:
Therapie. 71(5)
Since August 9, 2004, the 2001 European Directive for clinical trials is applied to the French law. Since the 2006 implementing decree amending public health law on biomedical researches, safety data are managed by sponsor vigilant. Competent authori
Publikováno v:
Pharmaceutical Medicine. 26:153-164
Latin American pharmacovigilance systems have developed considerably since the early 1990s and have continued to strengthen. The aim of this article is to review and analyse pharmacovigilance regulatory requirements governing the pharmaceutical indus
Autor:
Pascal Bilbault, Chantal Belorgey, Faiez Zannad, Danielle Golinelli, Yannick Pletan, Michel Abiteboul, Delphine Bertram, Catherine Cornu, Olivier Chassany, Jacques Demotes-Mainard, Jean-Paul Demarez, Vincent Diebolt, Claude Dubray, Mats Ericson, Elisabeth Frija Orvoen, François Hirsch, Yves Juillet, Véronique Lamarque, Rémi Le Coent, Christian Libersa, Christine Marey, Brigitte Marchenay, Armelle Mijonnet, Valérie Plattner, Anne Raison, Patrick Rossignol, Philippe Rusch, Tabassome Simon
Publikováno v:
Therapies. 65:301-308
The aim of the Round Table was to make recommendations with regard to the imminent revision of the European Directive on clinical drug trials (2001/20/CE). While recognising the importance of compliance with this Directive, which is not optimal in so
Autor:
Pascal Bilbault, Chantal Belorgey, Faiez Zannad, Danielle Golinelli, Yannick Pletan, Michel Abiteboul, Delphine Bertram, Catherine Cornu, Olivier Chassany, Jacques Demotes-Mainard, Jean-Paul Demarez, Vincent Diebolt, Claude Dubray, Mats Ericson, Elisabeth Frija Orvoen, François Hirsch, Yves Juillet, Véronique Lamarque, Rémi Le Coent, Christian Libersa, Christine Marey, Brigitte Marchenay, Armelle Mijonnet, Valérie Plattner, Anne Raison, Patrick Rossignol, Philippe Rusch, Tabassome Simon
Publikováno v:
Therapies. 65:291-299
Resume L’objet de cette Table Ronde etait de proposer des recommandations en vue d’une prochaine revision de la Directive communautaire portant sur les essais cliniques de medicaments (2001/20/CE). Tout en reconnaissant l’importance de faire re